Variant-adapted COVID shot approved in U.K.; Novavax requests U.S. booster nod
By
Alicia Lasek
Aug 16, 2022
Novavax wants its U.S. vaccine authorization to extend to a booster shot, and the U.K. has approved a two-component vaccine that directly tackles the omicron variant.
Senior care scores some wins in congressional budget deal
By
Alicia Lasek
Dec 21, 2022
A Congressional spending package for fiscal year 2023 supports key healthcare policy requests important to long-term care industry stakeholders, saving some clinicians and services from feared cuts.
Senior care association opens free COVID test kit program to all providers
By
Alicia Lasek
Jan 09, 2023
Industry advocate LeadingAge is now offering free test kits to long-term care providers in all care settings and communities.
Clinical briefs for Monday, June 26
By
Alicia Lasek
Jun 26, 2023
GAO chides CMS over delayed nursing home reporting, antipsychotic transparency … Over 1.3 billion globally will have diabetes by 2050, study finds … Moderna requests FDA authorization for updated COVID...
Stanford to test antiviral pills as long COVID treatment
By
Alicia Lasek
Nov 28, 2022
Investigators plan to test whether the antiviral drug Paxlovid will relieve symptoms of the syndrome known as long COVID, also called post-acute sequelae of COVID-19.
Clinical briefs for Monday, Oct. 17
By
Alicia Lasek
Oct 17, 2022
CDC reports higher-than-normal flu cases, upticks in Southeast and South-Central U.S. … Long COVID found among 29% of survivors, women and severely ill most affected … Biden to sign order aiming to...
Clinical briefs for Tuesday, Dec. 6
By
Alicia Lasek
Dec 06, 2022
Having a sense of purpose can lower the risk of death from any cause … New nursing home quality coalition Moving Forward requests feedback … Researchers granted $7.3M from CDC to study long COVID …...
Clinical briefs for Wednesday, March 15
By
Alicia Lasek
Mar 15, 2023
Bill would require senior living communities to recognize essential caregivers … Home oxygen groups request continued flexibilities at PHE’s end … Medicare enrollment has surged among kidney failure...
Alzheimer’s drug donanemab finds late-stage trial success, safety concerns
By
Alicia Lasek
May 04, 2023
The experimental drug donanemab appears to halt the progression of Alzheimer’s disease and slow certain measures of clinical decline, new trial data show.
Survey: U.S. neurologists would prescribe Leqembi if fully approved
By
Alicia Lasek
Apr 12, 2023
A “healthy proportion” of surveyed neurologists have already begun prescribing the treatment, and nearly all said they planned to do so if traditional FDA approval is granted.